Cymabay Therapeutics Inc (CBAY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

7575 GATEWAY BOULEVARD NEWARK, CA 94560

Cymabay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases.

Data as of 2021-03-06 10:45:24 -0500
Market Cap315.158 Million Shares Outstanding68.887 Million Avg 30-day Volume1.587 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.65842 52-week High/Low9.06 / 1.21 Next Earnings Date2021-03-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CBAY instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 1 (0.06%) 0 (0.0%)
Funds Holding: 141 119 18.49% 44 (2.65%) 38 (2.37%) 15.79%
13F shares: 56.024 Million 58.052 Million -3.49% 30.757 Million 32.643 Million -5.78%
% Ownership 81.3278 84.2715 -3.49% 44.6477 47.3864 -5.78%
New Positions: 43 29 48.28% 16 9 77.78%
Increased Positions 41 28 46.43% 10 10 0.0%
Closed Positions 20 23 -13.04% 10 14 -28.57%
Reduced Positions 35 42 -16.67% 15 17 -11.76%
Total Calls 342.204 Thousand 514.356 Thousand -33.47% 65.5 Thousand 46.6 Thousand 40.56%
Total Puts 693.118 Thousand 131.377 Thousand 427.58% 419.9 Thousand 33.4 Thousand 1157.19%
PUT/CALL Ratio 2.03 0.26 680.77% 6.41 0.72 790.28%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBAY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBAY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAH SUJAL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-26 2

MCWHERTER CHARLES CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-01-26 2

WILLS ROBERT JAMES

  • Director
0 2021-01-26 2

TRUEX PAUL F

  • Director
0 2021-01-26 2

LOEWY CAROLINE M

  • Director
0 2021-01-26 2

MENOLD DANIEL VICE PRESIDENT, FINANCE

  • Officer
0 2021-01-26 2

DICKINSON KLARA CHIEF REGULATORY OFFICER

  • Officer
0 2021-01-26 2

EMSTER KURT VON

  • Director
0 2021-01-26 2

QUINLAN PAUL T GENERAL COUNSEL

  • Officer
0 2021-01-26 3

AVORO CAPITAL ADVISORS LLC

AGHAZADEH BEHZAD

  • 10% Owner
10,300,000 2020-08-03 1

VON EMSTER KURT

  • Director
0 2020-05-15 1

DORLING JANET CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-08-05 0

GOLDFISCHER CARL

  • Director
0 2019-02-07 0

BOUDES POL F CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-29 0

WEILAND ROBERT J.

  • Director
0 2019-01-29 0

STEIN EVAN A.

  • Director
0 2019-01-29 0

BOOTH ROBERT F.

  • Director
0 2019-01-29 0

MARTIN ROBERT L. SVP, NONCLINICAL & MANUF.

  • Officer
No longer subject to file 2018-01-24 0

OMARA PATRICK J. SVP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2018-01-24 0

VAN WART HAROLD PRESIDENT AND CEO

  • Officer
  • Director
0 2017-01-19 0

ROSEMARK KIRK V.P. REGULATORY & QUALITY

  • Officer
0 2017-01-19 0

KUMAR HARI

  • Director
0 2015-06-24 0

LANGE LOUIS G

  • Director
0 2015-06-24 0

PENHOET EDWARD

  • Director
0 2015-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

QUINLAN PAUL T - Officer GENERAL COUNSEL

2021-01-28 14:48:38 -0500 2021-01-26 A 22,167 a 22,167 direct

EMSTER KURT VON - Director

2021-02-01 19:15:00 -0500 2021-01-26 A 32,000 a 32,000 direct

TRUEX PAUL F - Director

2021-01-28 15:00:52 -0500 2021-01-26 A 32,000 a 32,000 direct

MCWHERTER CHARLES - Officer CHIEF SCIENTIFIC OFFICER

2021-01-28 14:57:31 -0500 2021-01-26 A 112,000 a 112,000 direct

WILLS ROBERT JAMES - Director

2021-01-28 15:01:32 -0500 2021-01-26 A 32,000 a 32,000 direct

DICKINSON KLARA - Officer CHIEF REGULATORY OFFICER

2021-01-28 14:58:23 -0500 2021-01-26 A 66,500 a 66,500 direct

SHAH SUJAL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-28 14:56:35 -0500 2021-01-26 A 287,000 a 287,000 direct

LOEWY CAROLINE M - Director

2021-01-28 15:00:06 -0500 2021-01-26 A 32,000 a 32,000 direct

MENOLD DANIEL - Officer VICE PRESIDENT, FINANCE

2021-01-28 14:59:10 -0500 2021-01-06 A 42,000 a 42,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 22:15:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 21:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 21:15:02 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 20:45:02 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 20:15:05 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 19:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 19:15:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 18:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 18:15:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 17:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 17:15:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 16:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 16:15:02 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 15:45:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 15:15:03 UTC -0.5448 0.6148 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 14:45:03 UTC -0.551 0.621 250000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 14:15:03 UTC -0.551 0.621 400000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 13:45:03 UTC -0.551 0.621 400000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 13:15:03 UTC -0.551 0.621 400000
CYMABAY THERAPEUTICS INC CBAY 2021-03-05 12:45:03 UTC -0.551 0.621 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments